Patent details
EP1534390
Title:
3'- (2Z)- 1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE HYDRAZINO -2'-HYDROXY- 1,1'-BIPHENYL -3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)
Basic Information
- Publication number:
- EP1534390
- PCT Application Number:
- PCT/US/2003/016255
- Type:
- European Patent Granted for LU
- Legal Status:
- Expired
- Application number:
- EP037313350
- PCT Publication Number:
- WO/2003/098992
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- 3'- (2Z)- 1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE HYDRAZINO -2'-HYDROXY- 1,1'-BIPHENYL -3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)
- French Title of Invention:
- ACIDE 3'- (2Z)- 1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE HYDRAZINO -2'-HYDROXY- 1,1'-BIPHENYL -3-CARBOXYLIQUE BIS-(MONOETHANOLAMINE)
- German Title of Invention:
- 3'- (2Z)- 1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDEN HYDRAZINO -2'-HYDROXY- 1,1'-BIPHENYL -3-CARBONSAURE-BIS-(MONOETHANOLAMIN)
- SPC Number:
-
Dates
- Filing date:
- 21/05/2003
- Grant date:
- 23/12/2009
- EP Publication Date:
- 23/12/2009
- PCT Publication Date:
- 04/12/2003
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/06/2005
- EP B1 Publication Date:
- 23/12/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 21/05/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 17/12/2015
-
-
- Name:
- NOVARTIS AG
- Address:
- LICHTSTRASSE 35, 4056, BASEL, Switzerland (CH)
History of Owners
- From:
- 17/12/2015
- To:
- 17/12/2015
- Name:
- GLAXO GROUP LIMITED
- Address:
- 980 GREAT WEST ROAD, BRENTFORD, MIDDLESEX TW8 9GS, United Kingdom (GB)
- Name:
- NOVARTIS PHARMA AG
- Address:
- LICHTSTRASSE 35, 4056, BASEL, Switzerland (CH)
- From:
- 30/12/2009
- To:
- 16/12/2015
- Name:
- GlaxoSmithKline LLC
- Address:
- One Franklin Plaza P.O. Box 7929, Philadelphia, PA 19101, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 03/02/2010
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- MOORE Stephen
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 382871 P
- Priority Date:
- 22/05/2002
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
A61P 7/02;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 12/05/2022
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 300 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date |
Document type |
Number of pages |